Sari IK, Pamungkas J, Mustopa AZ, Wibawan IWT, Mamangkey J, Chairunnisa S, et al. Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate. HAYATI J Biosci [Internet]. 2025 Dec. 31 [cited 2026 Jan. 2];33(3):556-65. Available from: https://journal.ipb.ac.id/hayati/article/view/68333